{"gene":"FCER1G","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":1996,"finding":"The dual phosphorylated FcεRIγ ITAM binds to the tandem SH2 domains of p72Syk with high affinity (Kd ~1.4 nM); both SH2 domains contribute cooperatively, with the preferred orientation placing the N-terminal phosphotyrosine at the C-terminal SH2 domain and the C-terminal phosphotyrosine at the N-terminal SH2 domain. Monophosphorylated peptides bind with substantially lower affinity.","method":"Scintillation proximity assay with 125I-labeled ITAM peptides, competition binding with C-terminal and N-terminal SH2 domain knockouts, saturation binding isotherms","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with defined peptides, domain mutagenesis knockouts, quantitative binding parameters, multiple orthogonal approaches in a single rigorous study","pmids":["8810294"],"is_preprint":false},{"year":1998,"finding":"FcεRIγ can substitute for ζ/η chains as a signal-transducing subunit in TCR complexes during T cell development; mice lacking all three ζ-family members (ζ, η, FcεRIγ) still generate low numbers of αβ-T cells, demonstrating that TCR surface complexes lacking any ζ-family dimer can transduce developmental signals. ζ/η and FcεRIγ have distinct expression patterns correlated with thymus dependency.","method":"Genetic knockout mice lacking ζ/η, FcεRIγ, or all three; T cell development phenotyping by flow cytometry","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined developmental phenotype, triple-KO epistasis, replicated across multiple genotypes in single study","pmids":["9529325"],"is_preprint":false},{"year":1999,"finding":"PIR-A3 physically interacts with FcεRIγ via an arginine residue (Arg632) in the PIR-A3 transmembrane domain; this interaction is required for PIR-A3 to deliver activation signals (nitric oxide production synergizing with IFN-γ) in macrophages.","method":"Cotransfection of CD4-PIR-A3 chimeric receptors in 293T cells, co-immunoprecipitation with endogenous FcεRIγ in ANA-1 macrophages, Arg632 point mutant, nitric oxide assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — co-IP with mutant validation plus functional readout (NO production), two cell systems, single lab","pmids":["10477705"],"is_preprint":false},{"year":2003,"finding":"FcεRIγ expression is rate-limiting for surface expression of the high-affinity IgE receptor (FcεRI) on dendritic cells. Without FcεRIγ, FcεRIα accumulates as an immature, core-glycosylated form in the ER; co-expression of FcεRIγ allows FcεRIα to acquire complex glycosylation and traffic through the Golgi to the cell surface. FcεRIγ co-precipitates with FcεRIα.","method":"Co-immunoprecipitation, Western blot (glycosylation analysis), confocal microscopy/colocalization, monocyte-derived DC differentiation from atopic vs. normal donors","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, glycosylation biochemistry, subcellular localization imaging, multiple orthogonal methods, replicated across donor groups","pmids":["12671054"],"is_preprint":false},{"year":2004,"finding":"Rat NKp46 associates with both FcεRIγ and CD3ζ as signal-transducing adaptor proteins, enabling NK cell cytotoxicity; this was demonstrated by co-immunoprecipitation from IL-2-activated NK cell lysates and confirmed by redirected lysis and F(ab')2 blocking assays.","method":"Immunoprecipitation/Western blot, redirected lysis assay, F(ab')2 blocking","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP from primary NK cells plus functional cytotoxicity assay, single lab","pmids":["15356098"],"is_preprint":false},{"year":2007,"finding":"Antiallergic drug azelastine inhibits IgE-induced phosphorylation of FcεRIγ ITAM tyrosines in RBL-2H3 cells without affecting FcεRIγ mRNA or protein levels or the amount of γ chain assembled into IgE-bound FcεRI, indicating that ITAM tyrosine phosphorylation is a discrete step required for FcεRI signaling cascade initiation.","method":"Immunoprecipitation, Western blot for phospho-γ chain, Northern blot for mRNA levels, pharmacological inhibition in RBL-2H3 cells","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean biochemical dissection of phosphorylation vs. expression, single lab, single cell system","pmids":["17499203"],"is_preprint":false},{"year":2011,"finding":"Hypomethylation of the FCER1G promoter drives FcεRIγ transcription and surface FcεRI expression on monocytes; patch methylation luciferase reporter assay confirmed direct methylation-dependent repression of the FCER1G promoter, and treatment of healthy monocytes with 5-azacytidine reduced methylation and induced FcεRIγ transcription and surface FcεRI.","method":"Bisulfite sequencing, patch methylation luciferase reporter assay, 5-azacytidine demethylation, real-time RT-PCR, Western blot, flow cytometry","journal":"Allergy","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — functional reporter assay with patch methylation directly demonstrates causality, supported by pharmacological demethylation and multiple quantitative readouts, single lab","pmids":["22150093"],"is_preprint":false},{"year":2013,"finding":"Mincle and MCL form heteromers on the cell surface; MCL associates with FcεRIγ via Mincle, forming a Mincle/MCL/FcεRIγ trimeric complex. Association with MCL and FcεRIγ increases Mincle surface expression and enhances phagocytosis of antibody-coated beads.","method":"Co-immunoprecipitation, flow cytometry, phagocytosis assay in rat primary cells and cell lines","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with functional phagocytosis readout, multiple cell types, single lab","pmids":["23921530"],"is_preprint":false},{"year":2013,"finding":"FCER1G promoter activity is methylation-sensitive: full methylation of the promoter regulatory element reduces luciferase reporter activity to ~36% of mock-methylated controls, directly demonstrating that DNA methylation represses FCER1G transcription.","method":"Patch-methylation luciferase reporter assay with full vs. mock methylated FCER1G promoter constructs","journal":"Zhong nan da xue xue bao. Yi xue ban","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reporter reconstitution with defined methylation, single lab, single method","pmids":["23456064"],"is_preprint":false},{"year":2014,"finding":"Type II phosphatidylinositol 4-kinases (PtdIns 4-kinases) physically associate with the FcεRIγ subunit; this association increases threefold upon FcεRI ligation, and mutation of both canonical ITAM tyrosines (Y65 and Y76) abolishes the interaction, demonstrating that ITAM tyrosines are required for PtdIns 4-kinase coupling to FcεRIγ.","method":"Anti-FcεRIγ immunoprecipitation with PtdIns 4-kinase activity assay, ITAM tyrosine point mutants (Y65F, Y76F), RBL-2H3 cells","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with enzymatic activity readout and mutagenesis validation, single lab","pmids":["24481753"],"is_preprint":false},{"year":2017,"finding":"FcεRIγ (Fcer1g) on non-B myeloid APCs negatively regulates B cell responses; mice lacking Fcer1g showed a markedly enhanced and prolonged extrafollicular plasmablast response, and this enhancement was CD40L-dependent, placing FcεRIγ on myeloid APCs in a pathway that downregulates T cell help.","method":"Adoptive transfer into Fcer1g-/- and Myd88-/- recipient mice, flow cytometry, antibody response quantification, CD40L blockade epistasis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype, epistasis via CD40L blockade, single lab","pmids":["28659358"],"is_preprint":false},{"year":2018,"finding":"FcεRIγ is required for NKp30 cell-surface expression and function in IL-15-induced NKp30+CD8+ T cells; concomitant induction of FcεRIγ (via promoter demethylation) and NKp30 occurs, and FcεRIγ acquisition correlates with Syk and PLZF expression, enabling NK-like antitumor cytotoxicity.","method":"IL-15 stimulation of CD8+ T cells, flow cytometry, promoter demethylation analysis, in vitro cytotoxicity assays, xenograft mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter demethylation linked to expression, functional in vitro and in vivo readouts, single lab","pmids":["29895693"],"is_preprint":false},{"year":2019,"finding":"FcεRIγ on NK cells stabilizes NKp46 surface expression and limits NK cell ability to restrain virus-specific CD8+ T cells during LCMV infection; Fcer1g-/- mice showed enhanced CD8+ T cell responses and rapid viral control. FcεRIγ did not affect NKp46 mRNA but specifically stabilized its surface protein.","method":"Fcer1g-/- mice (genetic KO), flow cytometry for NKp46 and other activating receptors, viral load quantification, CD8+ T cell expansion measurement during LCMV infection","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic KO with defined in vivo immunological phenotype, mechanistic distinction of surface stabilization vs. transcription, multiple readouts, single lab","pmids":["31220194"],"is_preprint":false},{"year":2019,"finding":"DCAR1, a C-type lectin receptor on rat myeloid cells, associates with FcεRIγ as its activating adaptor protein, enabling efficient phagocytosis of antibody-coated beads and reactive oxygen species production upon DCAR1 crosslinking on eosinophils.","method":"Co-immunoprecipitation, phagocytosis assay, ROS assay, monoclonal antibody-based characterization","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with functional readouts (phagocytosis, ROS), single lab","pmids":["31134097"],"is_preprint":false},{"year":2019,"finding":"Syk recruitment to FcεRIγ involves multivalent cis and trans docking configurations on γ homodimers; multivalent interactions improve cis-oriented binding by ~1000-fold. Autophosphorylation of Syk Y130 in interdomain A alters the bias for cis binding. Short distances between paired γ ITAM pairs are required for trans docking, as demonstrated in γ-KO cells reconstituted with disulfide-linked γ subunits or monomeric ITAM/hemITAM γ-chimeras.","method":"Molecular dynamics simulation, hybrid MD/worm-like chain polymer modeling, live cell imaging, reconstitution in γ-KO cells with disulfide-linked γ and chimeric ITAM constructs, phosphomimetic Y130E Syk mutant","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — computational modeling validated by cell reconstitution experiments with engineered constructs and mutagenesis, multiple orthogonal approaches","pmids":["31216232"],"is_preprint":false},{"year":2021,"finding":"Rhesus macaque activating KIR (KIR3DS05), which contains a positively charged arginine in its transmembrane domain, associates with FcεRIγ (not DAP12) as its signal-transducing adaptor; this association results in increased and stabilized KIR3DS05 surface expression. Ligand binding (Mamu-A1*001 and A1*011) triggers signal transduction in the presence of FcεRIγ but not DAP12.","method":"Co-immunoprecipitation of transfected and primary cells, flow cytometry, signaling assays with specific MHC-I ligands","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP in two cell systems plus functional signaling readout, single lab","pmids":["33968088"],"is_preprint":false},{"year":2022,"finding":"FcεRIγ (FcRγ) upregulation in NK cells is dependent on cell proliferation driven by IL-2, IL-15, or IL-12, sensitive to mTOR suppression, and inhibited by TGFβ or IFNα; diminished proliferation (e.g., rapamycin treatment) leads to adaptive-like FcRγ-/low NK cell phenotype. Lower FcRγ protein expression was observed in NK cells during rapamycin treatment in vivo.","method":"Flow cytometry in lung transplant patients on rapamycin, cytokine stimulation experiments, mTOR inhibitor treatment, TGFβ/IFNα treatment of NK cells","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro mechanistic dissection with multiple cytokines and inhibitors plus in vivo clinical correlation, single lab","pmids":["36066491"],"is_preprint":false},{"year":2024,"finding":"Covalent small molecules identified by HTS disrupt the interaction between the FCER1G phospho-ITAM and the SYK tandem SH2 domains (SYK-tSH2) by covalently modifying SYK-tSH2; the FCER1G p-ITAM interaction with SYK-tSH2 enables SYK activation via phosphorylation.","method":"High-throughput screen, TR-FRET binding assay, orthogonal protein-protein interaction assay, biochemical and biophysical characterization of inhibitor binding","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro biochemical assay with orthogonal validation of interaction disruption, multiple chemotypes tested, single lab","pmids":["38359047"],"is_preprint":false},{"year":2025,"finding":"USP5 deubiquitylase interacts with FcεRIγ in mast cells, reverses K48-linked polyubiquitylation of FcεRIγ (added by E3 ligase Cbl-b), and thereby stabilizes FcεRIγ protein. USP5 knockdown increases Cbl-b binding to FcεRIγ, enhancing its polyubiquitylation and degradation, and attenuates IgE-induced mast cell activation (β-hexosaminidase/histamine release) and allergic inflammation in mice.","method":"Co-immunoprecipitation, ubiquitylation assays (K48-linkage specific), siRNA knockdown of USP5 in mast cells and HEK293T cells, USP5 inhibitor WP1130, in vivo mouse allergy models","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — co-IP, linkage-specific ubiquitylation assay, genetic knockdown, pharmacological inhibition, and in vivo validation, multiple orthogonal methods","pmids":["40729432"],"is_preprint":false},{"year":2026,"finding":"In double-negative T (DNT) cells, FcεRIγ mediates IgG1-stimulated antibody-dependent cellular cytotoxicity (ADCC) against tumor cells via the FcεRIγ/Syk/AKT/NF-κB signaling pathway; Fcer1g-deficient DNT cells failed to respond to IgG1 stimulation, and Syk inhibition reduced cytotoxicity and phosphorylation of AKT and NF-κB. Combined DNT cells + tumor antibody therapy was abolished by Fcer1g deficiency in subcutaneous tumor models.","method":"Fcer1g knockout DNT cells, in vitro cytotoxicity assays, Syk inhibitor, Western blot for pathway phosphorylation (AKT, NF-κB), subcutaneous mouse tumor model","journal":"Journal of molecular cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO + Syk inhibitor epistasis with defined signaling readouts and in vivo tumor model, single lab","pmids":["41481135"],"is_preprint":false}],"current_model":"FcεRIγ (FCER1G) is a transmembrane adaptor/signaling subunit that couples multiple immune receptors (FcεRI, FcγRs, NKp46, NKp30, PIR-A, Mincle/MCL, KIR2DL4, DCAR1, and others) to intracellular signaling by presenting its dual-phosphotyrosine ITAM to the tandem SH2 domains of Syk (Kd ~1.4 nM, cooperative binding); ITAM phosphorylation activates the Syk/AKT/NF-κB pathway, and FcεRIγ protein stability is controlled by a USP5 (deubiquitylase) / Cbl-b (E3 ligase) K48-ubiquitylation axis, while its transcription is epigenetically regulated by promoter DNA methylation."},"narrative":{"mechanistic_narrative":"FCER1G (FcεRIγ) is a transmembrane ITAM-bearing adaptor subunit that couples a broad array of immune-activating receptors to intracellular tyrosine-kinase signaling [PMID:8810294, PMID:15356098]. Its central biochemical activity is presentation of a dual-phosphorylated ITAM to the tandem SH2 domains of Syk, which it binds with high affinity (Kd ~1.4 nM) in a cooperative, orientation-specific manner, whereas monophosphorylated ITAM binds far more weakly [PMID:8810294]; multivalent cis and trans docking configurations on γ homodimers, tuned by Syk Y130 autophosphorylation and by the spacing between paired ITAMs, further govern Syk recruitment [PMID:31216232]. ITAM tyrosine phosphorylation is a discrete, druggable initiation step in receptor signaling [PMID:17499203, PMID:38359047], and the assembled FcεRIγ/Syk module drives downstream activation through the Syk/AKT/NF-κB axis to mediate effector functions such as antibody-dependent cytotoxicity [PMID:41481135]. FcεRIγ acts as an obligate assembly and trafficking partner for partner receptors: it is rate-limiting for surface expression of FcεRIα, allowing it to mature past the ER and traffic to the cell surface [PMID:12671054], and it stabilizes the surface expression of NK-cell activating receptors NKp46 and NKp30 [PMID:31220194, PMID:29895693]. Through transmembrane charge-pair interactions it serves as the activating adaptor for diverse receptors including PIR-A, NKp46, Mincle/MCL, DCAR1, and activating KIR, enabling phagocytosis, ROS production, nitric oxide release, and cytotoxicity [PMID:10477705, PMID:15356098, PMID:23921530, PMID:31134097, PMID:33968088]. FcεRIγ abundance is controlled at multiple levels: its transcription is repressed by FCER1G promoter DNA methylation and induced upon demethylation [PMID:22150093, PMID:23456064], its surface availability is coupled to proliferation/mTOR signaling [PMID:36066491], and its protein stability is set by a K48-ubiquitylation switch in which Cbl-b targets it for degradation and the deubiquitylase USP5 reverses this to stabilize it [PMID:40729432]. Beyond its canonical activating role, FcεRIγ on myeloid antigen-presenting cells negatively regulates extrafollicular B-cell responses in a CD40L-dependent manner [PMID:28659358], and it can substitute for ζ/η chains in the TCR complex during T-cell development [PMID:9529325].","teleology":[{"year":1996,"claim":"Established the core biochemical logic of FcεRIγ signaling: how the phosphorylated ITAM is read by Syk, defining affinity, cooperativity, and orientation requirements.","evidence":"In vitro scintillation proximity and competition binding with 125I-ITAM peptides and SH2-domain knockout mutants","pmids":["8810294"],"confidence":"High","gaps":["Performed with isolated peptides and domains, not intact receptor complexes","Did not address kinase activation downstream of docking"]},{"year":1998,"claim":"Showed FcεRIγ is functionally interchangeable with ζ/η chains as a TCR signal-transducing subunit, revealing a shared ITAM-adaptor role across receptor families.","evidence":"Single and triple ζ-family knockout mice analyzed for αβ-T cell development by flow cytometry","pmids":["9529325"],"confidence":"High","gaps":["Did not define the molecular signaling differences between γ and ζ in the TCR","Low residual T cell numbers leave quantitative contribution unclear"]},{"year":1999,"claim":"Defined the transmembrane charge-pair mechanism by which a partner receptor (PIR-A3) physically engages FcεRIγ to deliver activation signals.","evidence":"Chimeric receptor cotransfection, co-IP with endogenous FcεRIγ, Arg632 point mutant, and nitric oxide functional assay","pmids":["10477705"],"confidence":"High","gaps":["Single receptor pairing; generality across receptors not yet shown","Downstream signaling steps not dissected"]},{"year":2003,"claim":"Revealed FcεRIγ as an obligate assembly/trafficking chaperone, rate-limiting for surface delivery of FcεRIα.","evidence":"Reciprocal co-IP, glycosylation maturation analysis, and confocal colocalization in monocyte-derived dendritic cells","pmids":["12671054"],"confidence":"High","gaps":["Mechanism of ER-to-Golgi escort not resolved at structural level","Did not address whether γ chaperones other partner receptors similarly"]},{"year":2004,"claim":"Extended the adaptor role to NK cytotoxicity by showing NKp46 uses FcεRIγ (and CD3ζ) for signal transduction.","evidence":"Co-IP from activated NK cells with redirected lysis and F(ab')2 blocking","pmids":["15356098"],"confidence":"Medium","gaps":["Rat system; single lab","Relative contribution of γ vs ζ not quantified"]},{"year":2007,"claim":"Isolated ITAM tyrosine phosphorylation as a discrete, separable step in signaling, distinct from receptor expression and assembly.","evidence":"Pharmacological inhibition (azelastine) with phospho-γ Western blot and mRNA/protein controls in RBL-2H3 cells","pmids":["17499203"],"confidence":"Medium","gaps":["Single cell line and single drug","Did not identify the kinase responsible for the phosphorylation step"]},{"year":2011,"claim":"Identified FCER1G promoter DNA methylation as a causal transcriptional control point governing FcεRIγ and surface FcεRI levels.","evidence":"Bisulfite sequencing, patch-methylation luciferase reporter, and 5-azacytidine demethylation in monocytes","pmids":["22150093"],"confidence":"High","gaps":["Methyltransferases/demethylases acting at the locus not identified","Physiological signals controlling methylation state unknown"]},{"year":2013,"claim":"Confirmed and extended the methylation-dependent repression of the FCER1G promoter and showed γ assembly into a Mincle/MCL trimeric complex enhances phagocytosis.","evidence":"Patch-methylation luciferase reporter; co-IP, flow cytometry, and phagocytosis assays in rat cells","pmids":["23456064","23921530"],"confidence":"Medium","gaps":["Reporter assays are in vitro reconstitutions","Stoichiometry and surface organization of the trimeric complex not resolved"]},{"year":2014,"claim":"Showed that ITAM tyrosines recruit effectors beyond Syk, coupling FcεRIγ to type II PtdIns 4-kinase upon receptor ligation.","evidence":"Anti-FcεRIγ IP with PtdIns 4-kinase activity assay and Y65F/Y76F ITAM mutants in RBL-2H3 cells","pmids":["24481753"],"confidence":"Medium","gaps":["Direct vs indirect (Syk-bridged) association not distinguished","Functional consequence of lipid kinase coupling not defined"]},{"year":2017,"claim":"Uncovered a negative-regulatory role for FcεRIγ on myeloid APCs in restraining B-cell responses, broadening its biology beyond direct activation.","evidence":"Adoptive transfer into Fcer1g-/- and Myd88-/- mice with CD40L blockade epistasis","pmids":["28659358"],"confidence":"Medium","gaps":["Receptor delivering the suppressive signal not identified","Molecular mechanism of CD40L-dependent downregulation unresolved"]},{"year":2018,"claim":"Linked FcεRIγ induction (via demethylation) to functional acquisition of NKp30 and NK-like cytotoxicity in CD8+ T cells.","evidence":"IL-15 stimulation, promoter demethylation analysis, cytotoxicity assays, and xenograft model","pmids":["29895693"],"confidence":"Medium","gaps":["Correlative coupling of γ, Syk, and PLZF; causal ordering not established","Single lab"]},{"year":2019,"claim":"Defined the biophysics of Syk recruitment (cis/trans multivalent docking, ITAM spacing, Y130 autophosphorylation bias) and showed FcεRIγ stabilizes NKp46 surface protein independent of transcription, with in vivo immunological consequences.","evidence":"MD/polymer modeling with γ-KO reconstitution and engineered constructs; Fcer1g-/- mice in LCMV infection; co-IP/functional assays for DCAR1","pmids":["31216232","31220194","31134097"],"confidence":"High","gaps":["Structural model of the multivalent docking states not experimentally resolved","Mechanism by which γ stabilizes partner surface protein not molecularly defined"]},{"year":2021,"claim":"Demonstrated adaptor specificity, showing activating KIR3DS05 selectively pairs with FcεRIγ rather than DAP12 for ligand-triggered signaling.","evidence":"Co-IP in transfected and primary cells with MHC-I ligand signaling assays","pmids":["33968088"],"confidence":"Medium","gaps":["Structural basis of adaptor selectivity not defined","Rhesus system; single lab"]},{"year":2022,"claim":"Identified proliferation/mTOR signaling as a post-transcriptional determinant of FcεRIγ protein abundance in NK cells.","evidence":"Cytokine and mTOR-inhibitor treatments of NK cells with in vivo rapamycin clinical correlation","pmids":["36066491"],"confidence":"Medium","gaps":["Molecular link between mTOR/proliferation and γ protein levels not defined","Correlative in vivo data"]},{"year":2024,"claim":"Validated the FcεRIγ ITAM–Syk-tSH2 interface as a tractable drug target via covalent small-molecule disruptors.","evidence":"HTS with TR-FRET and orthogonal PPI assays plus biophysical characterization of covalent SYK-tSH2 modification","pmids":["38359047"],"confidence":"Medium","gaps":["Cellular and in vivo efficacy not established","Selectivity against other tSH2 proteins not characterized"]},{"year":2025,"claim":"Established a ubiquitin-based control of FcεRIγ stability, defining the Cbl-b/USP5 K48-ubiquitylation switch that tunes mast cell activation.","evidence":"Co-IP, K48-linkage-specific ubiquitylation assays, USP5 siRNA/inhibitor, and in vivo mouse allergy models","pmids":["40729432"],"confidence":"High","gaps":["Signals that regulate Cbl-b/USP5 activity toward γ unknown","Whether this axis operates in non-mast-cell lineages not tested"]},{"year":2026,"claim":"Mapped the full effector signaling axis (FcεRIγ/Syk/AKT/NF-κB) underlying antibody-dependent cytotoxicity in double-negative T cells.","evidence":"Fcer1g-KO DNT cells, Syk inhibitor epistasis, phospho-AKT/NF-κB Western blots, and subcutaneous tumor model","pmids":["41481135"],"confidence":"Medium","gaps":["Intermediate steps between Syk and AKT/NF-κB not delineated","Single lab"]},{"year":null,"claim":"How the diverse upstream regulatory inputs (DNA methylation, mTOR/proliferation, and Cbl-b/USP5 ubiquitylation) are integrated to set FcεRIγ levels in a given cell, and the structural basis of its selective pairing with distinct partner receptors, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking transcriptional, translational, and degradative control","No high-resolution structure of γ–partner-receptor transmembrane assemblies"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,4,7,13,15]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,7,12]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,10,12,19]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,14,19]}],"complexes":["FcεRI (high-affinity IgE receptor)","Mincle/MCL/FcεRIγ trimeric complex","TCR-CD3 complex"],"partners":["SYK","FCER1A","NCR1 (NKP46)","NCR3 (NKP30)","CLEC4D (MCL)","USP5","CBLB","PIRA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P30273","full_name":"High affinity immunoglobulin epsilon receptor subunit gamma","aliases":["Fc receptor gamma-chain","FcRgamma","Fc-epsilon RI-gamma","IgE Fc receptor subunit gamma","FceRI gamma"],"length_aa":86,"mass_kda":9.7,"function":"Adapter protein containing an immunoreceptor tyrosine-based activation motif (ITAM) that transduces activation signals from various immunoreceptors. As a component of the high-affinity immunoglobulin E (IgE) receptor, mediates allergic inflammatory signaling in mast cells. As a constitutive component of interleukin-3 receptor complex, selectively mediates interleukin 4/IL4 production by basophils, priming T-cells toward effector T-helper 2 subset. Associates with pattern recognition receptors CLEC4D and CLEC4E to form a functional signaling complex in myeloid cells. Binding of mycobacterial trehalose 6,6'-dimycolate (TDM) to this receptor complex leads to phosphorylation of ITAM, triggering activation of SYK, CARD9 and NF-kappa-B, consequently driving maturation of antigen-presenting cells and shaping antigen-specific priming of T-cells toward effector T-helper 1 and T-helper 17 cell subtypes. May function cooperatively with other activating receptors. Functionally linked to integrin beta-2/ITGB2-mediated neutrophil activation. Also involved in integrin alpha-2/ITGA2-mediated platelet activation","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P30273/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FCER1G","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FCER1G","total_profiled":1310},"omim":[{"mim_id":"616802","title":"T CELL-INTERACTING ACTIVATING RECEPTOR ON MYELOID CELLS 1; TARM1","url":"https://www.omim.org/entry/616802"},{"mim_id":"616560","title":"CD300H ANTIGEN; CD300H","url":"https://www.omim.org/entry/616560"},{"mim_id":"616301","title":"CD300 ANTIGEN-LIKE FAMILY, MEMBER D; CD300LD","url":"https://www.omim.org/entry/616301"},{"mim_id":"610705","title":"CD300 ANTIGEN-LIKE FAMILY, MEMBER B; CD300LB","url":"https://www.omim.org/entry/610705"},{"mim_id":"610665","title":"Fc FRAGMENT OF IgG RECEPTOR IIIb; FCGR3B","url":"https://www.omim.org/entry/610665"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":416.9},{"tissue":"lymphoid tissue","ntpm":448.7}],"url":"https://www.proteinatlas.org/search/FCER1G"},"hgnc":{"alias_symbol":["FcepsilonRIgamma"],"prev_symbol":[]},"alphafold":{"accession":"P30273","domains":[{"cath_id":"1.20.5","chopping":"20-63","consensus_level":"medium","plddt":79.3155,"start":20,"end":63}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30273","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30273-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30273-F1-predicted_aligned_error_v6.png","plddt_mean":72.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FCER1G","jax_strain_url":"https://www.jax.org/strain/search?query=FCER1G"},"sequence":{"accession":"P30273","fasta_url":"https://rest.uniprot.org/uniprotkb/P30273.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30273/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30273"}},"corpus_meta":[{"pmid":"12671054","id":"PMC_12671054","title":"Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12671054","citation_count":95,"is_preprint":false},{"pmid":"23921530","id":"PMC_23921530","title":"Mincle, the receptor for mycobacterial cord factor, forms a functional receptor complex with MCL and FcεRI-γ.","date":"2013","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23921530","citation_count":91,"is_preprint":false},{"pmid":"22150093","id":"PMC_22150093","title":"Demethylation of the FCER1G promoter leads to FcεRI overexpression on monocytes of patients with atopic dermatitis.","date":"2011","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/22150093","citation_count":65,"is_preprint":false},{"pmid":"29895693","id":"PMC_29895693","title":"Distinct human circulating NKp30+FcεRIγ+CD8+ T cell population exhibiting high natural killer-like antitumor potential.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29895693","citation_count":62,"is_preprint":false},{"pmid":"15356098","id":"PMC_15356098","title":"Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15356098","citation_count":59,"is_preprint":false},{"pmid":"8810294","id":"PMC_8810294","title":"Interaction of phosphorylated FcepsilonRIgamma immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8810294","citation_count":54,"is_preprint":false},{"pmid":"31220194","id":"PMC_31220194","title":"NK cell-intrinsic FcεRIγ limits CD8+ T-cell expansion and thereby turns an acute into a chronic viral infection.","date":"2019","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/31220194","citation_count":44,"is_preprint":false},{"pmid":"9529325","id":"PMC_9529325","title":"T cell development in mice lacking all T cell receptor zeta family members (Zeta, eta, and FcepsilonRIgamma).","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9529325","citation_count":42,"is_preprint":false},{"pmid":"36066491","id":"PMC_36066491","title":"Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36066491","citation_count":37,"is_preprint":false},{"pmid":"34357379","id":"PMC_34357379","title":"FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.","date":"2021","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/34357379","citation_count":31,"is_preprint":false},{"pmid":"10477705","id":"PMC_10477705","title":"Functional association of FcepsilonRIgamma with arginine(632) of paired immunoglobulin-like receptor (PIR)-A3 in murine macrophages.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10477705","citation_count":27,"is_preprint":false},{"pmid":"28659358","id":"PMC_28659358","title":"B Cell-Extrinsic Myd88 and Fcer1g Negatively Regulate Autoreactive and Normal B Cell Immune Responses.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28659358","citation_count":26,"is_preprint":false},{"pmid":"22401598","id":"PMC_22401598","title":"Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia.","date":"2012","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22401598","citation_count":22,"is_preprint":false},{"pmid":"31867015","id":"PMC_31867015","title":"Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31867015","citation_count":22,"is_preprint":false},{"pmid":"34115526","id":"PMC_34115526","title":"FCER1G and PTGS2 Serve as Potential Diagnostic Biomarkers of Acute Myocardial Infarction Based on Integrated Bioinformatics Analyses.","date":"2021","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/34115526","citation_count":20,"is_preprint":false},{"pmid":"26712042","id":"PMC_26712042","title":"NK cells lacking FcεRIγ are associated with reduced liver damage in chronic hepatitis C virus infection.","date":"2016","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26712042","citation_count":18,"is_preprint":false},{"pmid":"31216232","id":"PMC_31216232","title":"Combinatorial diversity of Syk recruitment driven by its multivalent engagement with FcεRIγ.","date":"2019","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/31216232","citation_count":17,"is_preprint":false},{"pmid":"22664044","id":"PMC_22664044","title":"Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.","date":"2012","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/22664044","citation_count":15,"is_preprint":false},{"pmid":"36012903","id":"PMC_36012903","title":"FCER1G Gene Hypomethylation in Patients with Rheumatoid Arthritis.","date":"2022","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36012903","citation_count":9,"is_preprint":false},{"pmid":"38359047","id":"PMC_38359047","title":"Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/38359047","citation_count":9,"is_preprint":false},{"pmid":"33968088","id":"PMC_33968088","title":"Rhesus Macaque Activating Killer Immunoglobulin-Like Receptors Associate With Fc Receptor Gamma (FCER1G) and Not With DAP12 Adaptor Proteins Resulting in Stabilized Expression and Enabling Signal Transduction.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33968088","citation_count":7,"is_preprint":false},{"pmid":"31134097","id":"PMC_31134097","title":"Dendritic Cell Activating Receptor 1 (DCAR1) Associates With FcεRIγ and Is Expressed by Myeloid Cell Subsets in the Rat.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31134097","citation_count":6,"is_preprint":false},{"pmid":"23456064","id":"PMC_23456064","title":"[Construction of special reporter to detect DNA methylation regulatory activity in FCER1G gene promoter through patch-methylation].","date":"2013","source":"Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23456064","citation_count":5,"is_preprint":false},{"pmid":"35711924","id":"PMC_35711924","title":"Identification of FCER1G related to Activated Memory CD4+ T Cells Infiltration by Gene Co-expression Network and Construction of a Risk Prediction Module in Diffuse Large B-Cell Lymphoma.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35711924","citation_count":4,"is_preprint":false},{"pmid":"37547005","id":"PMC_37547005","title":"Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37547005","citation_count":4,"is_preprint":false},{"pmid":"24481753","id":"PMC_24481753","title":"Type II phosphatidylinositol 4-kinases interact with FcεRIγ subunit in RBL-2H3 cells.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24481753","citation_count":3,"is_preprint":false},{"pmid":"39071704","id":"PMC_39071704","title":"FCER1G as a novel immune-associated blood biomarker in cardiogenic stroke.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/39071704","citation_count":3,"is_preprint":false},{"pmid":"17499203","id":"PMC_17499203","title":"Inhibition of IgE-mediated phosphorylation of FcepsilonRIgamma protein by antiallergic drugs in rat basophilic leukemia (RBL-2H3) cells: a novel action of antiallergic drugs.","date":"2007","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17499203","citation_count":3,"is_preprint":false},{"pmid":"40729432","id":"PMC_40729432","title":"USP5 deubiquitylates and stabilizes FcεRIγ to enhance IgE-induced mast cell activation and allergic inflammation.","date":"2025","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/40729432","citation_count":2,"is_preprint":false},{"pmid":"37081323","id":"PMC_37081323","title":"Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.","date":"2023","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/37081323","citation_count":2,"is_preprint":false},{"pmid":"39154664","id":"PMC_39154664","title":"Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction.","date":"2024","source":"SLAS discovery : advancing life sciences R & D","url":"https://pubmed.ncbi.nlm.nih.gov/39154664","citation_count":2,"is_preprint":false},{"pmid":"38143775","id":"PMC_38143775","title":"Skipping of FCER1G Exon 2 Is Common in Human Brain But Not Associated with the Alzheimer's Disease Genetic Risk Factor rs2070902.","date":"2023","source":"Journal of Alzheimer's disease reports","url":"https://pubmed.ncbi.nlm.nih.gov/38143775","citation_count":2,"is_preprint":false},{"pmid":"37821074","id":"PMC_37821074","title":"Identification of FCER1G as a cyclosporin A plus corticosteroid sensitization gene in female patients with Vogt-Koyanagi-Harada disease.","date":"2023","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/37821074","citation_count":1,"is_preprint":false},{"pmid":"39893200","id":"PMC_39893200","title":"Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39893200","citation_count":1,"is_preprint":false},{"pmid":"41758834","id":"PMC_41758834","title":"Fcer1g and St3gal1: Macrophage-associated angiogenesis biomarkers and therapeutic targets in sepsis-induced acute lung injury.","date":"2026","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41758834","citation_count":0,"is_preprint":false},{"pmid":"41994604","id":"PMC_41994604","title":"FCER1G: A multifunctional regulator in the immune microenvironment (Review).","date":"2026","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41994604","citation_count":0,"is_preprint":false},{"pmid":"41481135","id":"PMC_41481135","title":"FcεRIγ Reinforces Double-Negative T cell-mediated Antibody-dependent Cellular Cytotoxicity Against Tumor Cells.","date":"2026","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/41481135","citation_count":0,"is_preprint":false},{"pmid":"38915662","id":"PMC_38915662","title":"Development of a Time-Resolved Fluorescence Resonance Energy Transfer ultra-high throughput screening assay for targeting SYK and FCER1G interaction.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38915662","citation_count":0,"is_preprint":false},{"pmid":"41680182","id":"PMC_41680182","title":"A macrophage-induced subpopulation of mesenchymal cells expressing Fcer1g contributes to wound-induced fibrosis.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41680182","citation_count":0,"is_preprint":false},{"pmid":"42185776","id":"PMC_42185776","title":"Integration of single-cell RNA-sequencing and machine learning identifies GRN and FCER1G as potential peroxisomal targets in influenza pathogenesis.","date":"2026","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/42185776","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.21.689693","title":"Novel markers for haemogenic endothelium and haematopoietic progenitors in the mouse yolk sac","date":"2025-11-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.21.689693","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.07.25337258","title":"Artificial Intelligence Models for Predicting Molecular Pathway Activity in Spinal Cord Injury: A Systematic Review","date":"2025-10-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.07.25337258","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.19.683343","title":"Transcriptomic profiling of the middle temporal gyrus reveals differential glial/neuronal dysregulation across Alzheimer’s disease and aging","date":"2025-10-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.19.683343","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23643,"output_tokens":5445,"usd":0.076302,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14185,"output_tokens":5133,"usd":0.099625,"stage2_stop_reason":"end_turn"},"total_usd":0.175927,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"The dual phosphorylated FcεRIγ ITAM binds to the tandem SH2 domains of p72Syk with high affinity (Kd ~1.4 nM); both SH2 domains contribute cooperatively, with the preferred orientation placing the N-terminal phosphotyrosine at the C-terminal SH2 domain and the C-terminal phosphotyrosine at the N-terminal SH2 domain. Monophosphorylated peptides bind with substantially lower affinity.\",\n      \"method\": \"Scintillation proximity assay with 125I-labeled ITAM peptides, competition binding with C-terminal and N-terminal SH2 domain knockouts, saturation binding isotherms\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with defined peptides, domain mutagenesis knockouts, quantitative binding parameters, multiple orthogonal approaches in a single rigorous study\",\n      \"pmids\": [\"8810294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FcεRIγ can substitute for ζ/η chains as a signal-transducing subunit in TCR complexes during T cell development; mice lacking all three ζ-family members (ζ, η, FcεRIγ) still generate low numbers of αβ-T cells, demonstrating that TCR surface complexes lacking any ζ-family dimer can transduce developmental signals. ζ/η and FcεRIγ have distinct expression patterns correlated with thymus dependency.\",\n      \"method\": \"Genetic knockout mice lacking ζ/η, FcεRIγ, or all three; T cell development phenotyping by flow cytometry\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined developmental phenotype, triple-KO epistasis, replicated across multiple genotypes in single study\",\n      \"pmids\": [\"9529325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PIR-A3 physically interacts with FcεRIγ via an arginine residue (Arg632) in the PIR-A3 transmembrane domain; this interaction is required for PIR-A3 to deliver activation signals (nitric oxide production synergizing with IFN-γ) in macrophages.\",\n      \"method\": \"Cotransfection of CD4-PIR-A3 chimeric receptors in 293T cells, co-immunoprecipitation with endogenous FcεRIγ in ANA-1 macrophages, Arg632 point mutant, nitric oxide assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — co-IP with mutant validation plus functional readout (NO production), two cell systems, single lab\",\n      \"pmids\": [\"10477705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"FcεRIγ expression is rate-limiting for surface expression of the high-affinity IgE receptor (FcεRI) on dendritic cells. Without FcεRIγ, FcεRIα accumulates as an immature, core-glycosylated form in the ER; co-expression of FcεRIγ allows FcεRIα to acquire complex glycosylation and traffic through the Golgi to the cell surface. FcεRIγ co-precipitates with FcεRIα.\",\n      \"method\": \"Co-immunoprecipitation, Western blot (glycosylation analysis), confocal microscopy/colocalization, monocyte-derived DC differentiation from atopic vs. normal donors\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, glycosylation biochemistry, subcellular localization imaging, multiple orthogonal methods, replicated across donor groups\",\n      \"pmids\": [\"12671054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Rat NKp46 associates with both FcεRIγ and CD3ζ as signal-transducing adaptor proteins, enabling NK cell cytotoxicity; this was demonstrated by co-immunoprecipitation from IL-2-activated NK cell lysates and confirmed by redirected lysis and F(ab')2 blocking assays.\",\n      \"method\": \"Immunoprecipitation/Western blot, redirected lysis assay, F(ab')2 blocking\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP from primary NK cells plus functional cytotoxicity assay, single lab\",\n      \"pmids\": [\"15356098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Antiallergic drug azelastine inhibits IgE-induced phosphorylation of FcεRIγ ITAM tyrosines in RBL-2H3 cells without affecting FcεRIγ mRNA or protein levels or the amount of γ chain assembled into IgE-bound FcεRI, indicating that ITAM tyrosine phosphorylation is a discrete step required for FcεRI signaling cascade initiation.\",\n      \"method\": \"Immunoprecipitation, Western blot for phospho-γ chain, Northern blot for mRNA levels, pharmacological inhibition in RBL-2H3 cells\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean biochemical dissection of phosphorylation vs. expression, single lab, single cell system\",\n      \"pmids\": [\"17499203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hypomethylation of the FCER1G promoter drives FcεRIγ transcription and surface FcεRI expression on monocytes; patch methylation luciferase reporter assay confirmed direct methylation-dependent repression of the FCER1G promoter, and treatment of healthy monocytes with 5-azacytidine reduced methylation and induced FcεRIγ transcription and surface FcεRI.\",\n      \"method\": \"Bisulfite sequencing, patch methylation luciferase reporter assay, 5-azacytidine demethylation, real-time RT-PCR, Western blot, flow cytometry\",\n      \"journal\": \"Allergy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — functional reporter assay with patch methylation directly demonstrates causality, supported by pharmacological demethylation and multiple quantitative readouts, single lab\",\n      \"pmids\": [\"22150093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Mincle and MCL form heteromers on the cell surface; MCL associates with FcεRIγ via Mincle, forming a Mincle/MCL/FcεRIγ trimeric complex. Association with MCL and FcεRIγ increases Mincle surface expression and enhances phagocytosis of antibody-coated beads.\",\n      \"method\": \"Co-immunoprecipitation, flow cytometry, phagocytosis assay in rat primary cells and cell lines\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with functional phagocytosis readout, multiple cell types, single lab\",\n      \"pmids\": [\"23921530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FCER1G promoter activity is methylation-sensitive: full methylation of the promoter regulatory element reduces luciferase reporter activity to ~36% of mock-methylated controls, directly demonstrating that DNA methylation represses FCER1G transcription.\",\n      \"method\": \"Patch-methylation luciferase reporter assay with full vs. mock methylated FCER1G promoter constructs\",\n      \"journal\": \"Zhong nan da xue xue bao. Yi xue ban\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reporter reconstitution with defined methylation, single lab, single method\",\n      \"pmids\": [\"23456064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Type II phosphatidylinositol 4-kinases (PtdIns 4-kinases) physically associate with the FcεRIγ subunit; this association increases threefold upon FcεRI ligation, and mutation of both canonical ITAM tyrosines (Y65 and Y76) abolishes the interaction, demonstrating that ITAM tyrosines are required for PtdIns 4-kinase coupling to FcεRIγ.\",\n      \"method\": \"Anti-FcεRIγ immunoprecipitation with PtdIns 4-kinase activity assay, ITAM tyrosine point mutants (Y65F, Y76F), RBL-2H3 cells\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with enzymatic activity readout and mutagenesis validation, single lab\",\n      \"pmids\": [\"24481753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FcεRIγ (Fcer1g) on non-B myeloid APCs negatively regulates B cell responses; mice lacking Fcer1g showed a markedly enhanced and prolonged extrafollicular plasmablast response, and this enhancement was CD40L-dependent, placing FcεRIγ on myeloid APCs in a pathway that downregulates T cell help.\",\n      \"method\": \"Adoptive transfer into Fcer1g-/- and Myd88-/- recipient mice, flow cytometry, antibody response quantification, CD40L blockade epistasis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype, epistasis via CD40L blockade, single lab\",\n      \"pmids\": [\"28659358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FcεRIγ is required for NKp30 cell-surface expression and function in IL-15-induced NKp30+CD8+ T cells; concomitant induction of FcεRIγ (via promoter demethylation) and NKp30 occurs, and FcεRIγ acquisition correlates with Syk and PLZF expression, enabling NK-like antitumor cytotoxicity.\",\n      \"method\": \"IL-15 stimulation of CD8+ T cells, flow cytometry, promoter demethylation analysis, in vitro cytotoxicity assays, xenograft mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter demethylation linked to expression, functional in vitro and in vivo readouts, single lab\",\n      \"pmids\": [\"29895693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FcεRIγ on NK cells stabilizes NKp46 surface expression and limits NK cell ability to restrain virus-specific CD8+ T cells during LCMV infection; Fcer1g-/- mice showed enhanced CD8+ T cell responses and rapid viral control. FcεRIγ did not affect NKp46 mRNA but specifically stabilized its surface protein.\",\n      \"method\": \"Fcer1g-/- mice (genetic KO), flow cytometry for NKp46 and other activating receptors, viral load quantification, CD8+ T cell expansion measurement during LCMV infection\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO with defined in vivo immunological phenotype, mechanistic distinction of surface stabilization vs. transcription, multiple readouts, single lab\",\n      \"pmids\": [\"31220194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DCAR1, a C-type lectin receptor on rat myeloid cells, associates with FcεRIγ as its activating adaptor protein, enabling efficient phagocytosis of antibody-coated beads and reactive oxygen species production upon DCAR1 crosslinking on eosinophils.\",\n      \"method\": \"Co-immunoprecipitation, phagocytosis assay, ROS assay, monoclonal antibody-based characterization\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with functional readouts (phagocytosis, ROS), single lab\",\n      \"pmids\": [\"31134097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Syk recruitment to FcεRIγ involves multivalent cis and trans docking configurations on γ homodimers; multivalent interactions improve cis-oriented binding by ~1000-fold. Autophosphorylation of Syk Y130 in interdomain A alters the bias for cis binding. Short distances between paired γ ITAM pairs are required for trans docking, as demonstrated in γ-KO cells reconstituted with disulfide-linked γ subunits or monomeric ITAM/hemITAM γ-chimeras.\",\n      \"method\": \"Molecular dynamics simulation, hybrid MD/worm-like chain polymer modeling, live cell imaging, reconstitution in γ-KO cells with disulfide-linked γ and chimeric ITAM constructs, phosphomimetic Y130E Syk mutant\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — computational modeling validated by cell reconstitution experiments with engineered constructs and mutagenesis, multiple orthogonal approaches\",\n      \"pmids\": [\"31216232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Rhesus macaque activating KIR (KIR3DS05), which contains a positively charged arginine in its transmembrane domain, associates with FcεRIγ (not DAP12) as its signal-transducing adaptor; this association results in increased and stabilized KIR3DS05 surface expression. Ligand binding (Mamu-A1*001 and A1*011) triggers signal transduction in the presence of FcεRIγ but not DAP12.\",\n      \"method\": \"Co-immunoprecipitation of transfected and primary cells, flow cytometry, signaling assays with specific MHC-I ligands\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP in two cell systems plus functional signaling readout, single lab\",\n      \"pmids\": [\"33968088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FcεRIγ (FcRγ) upregulation in NK cells is dependent on cell proliferation driven by IL-2, IL-15, or IL-12, sensitive to mTOR suppression, and inhibited by TGFβ or IFNα; diminished proliferation (e.g., rapamycin treatment) leads to adaptive-like FcRγ-/low NK cell phenotype. Lower FcRγ protein expression was observed in NK cells during rapamycin treatment in vivo.\",\n      \"method\": \"Flow cytometry in lung transplant patients on rapamycin, cytokine stimulation experiments, mTOR inhibitor treatment, TGFβ/IFNα treatment of NK cells\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro mechanistic dissection with multiple cytokines and inhibitors plus in vivo clinical correlation, single lab\",\n      \"pmids\": [\"36066491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Covalent small molecules identified by HTS disrupt the interaction between the FCER1G phospho-ITAM and the SYK tandem SH2 domains (SYK-tSH2) by covalently modifying SYK-tSH2; the FCER1G p-ITAM interaction with SYK-tSH2 enables SYK activation via phosphorylation.\",\n      \"method\": \"High-throughput screen, TR-FRET binding assay, orthogonal protein-protein interaction assay, biochemical and biophysical characterization of inhibitor binding\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro biochemical assay with orthogonal validation of interaction disruption, multiple chemotypes tested, single lab\",\n      \"pmids\": [\"38359047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP5 deubiquitylase interacts with FcεRIγ in mast cells, reverses K48-linked polyubiquitylation of FcεRIγ (added by E3 ligase Cbl-b), and thereby stabilizes FcεRIγ protein. USP5 knockdown increases Cbl-b binding to FcεRIγ, enhancing its polyubiquitylation and degradation, and attenuates IgE-induced mast cell activation (β-hexosaminidase/histamine release) and allergic inflammation in mice.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitylation assays (K48-linkage specific), siRNA knockdown of USP5 in mast cells and HEK293T cells, USP5 inhibitor WP1130, in vivo mouse allergy models\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — co-IP, linkage-specific ubiquitylation assay, genetic knockdown, pharmacological inhibition, and in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"40729432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In double-negative T (DNT) cells, FcεRIγ mediates IgG1-stimulated antibody-dependent cellular cytotoxicity (ADCC) against tumor cells via the FcεRIγ/Syk/AKT/NF-κB signaling pathway; Fcer1g-deficient DNT cells failed to respond to IgG1 stimulation, and Syk inhibition reduced cytotoxicity and phosphorylation of AKT and NF-κB. Combined DNT cells + tumor antibody therapy was abolished by Fcer1g deficiency in subcutaneous tumor models.\",\n      \"method\": \"Fcer1g knockout DNT cells, in vitro cytotoxicity assays, Syk inhibitor, Western blot for pathway phosphorylation (AKT, NF-κB), subcutaneous mouse tumor model\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO + Syk inhibitor epistasis with defined signaling readouts and in vivo tumor model, single lab\",\n      \"pmids\": [\"41481135\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FcεRIγ (FCER1G) is a transmembrane adaptor/signaling subunit that couples multiple immune receptors (FcεRI, FcγRs, NKp46, NKp30, PIR-A, Mincle/MCL, KIR2DL4, DCAR1, and others) to intracellular signaling by presenting its dual-phosphotyrosine ITAM to the tandem SH2 domains of Syk (Kd ~1.4 nM, cooperative binding); ITAM phosphorylation activates the Syk/AKT/NF-κB pathway, and FcεRIγ protein stability is controlled by a USP5 (deubiquitylase) / Cbl-b (E3 ligase) K48-ubiquitylation axis, while its transcription is epigenetically regulated by promoter DNA methylation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FCER1G (FcεRIγ) is a transmembrane ITAM-bearing adaptor subunit that couples a broad array of immune-activating receptors to intracellular tyrosine-kinase signaling [#0, #4]. Its central biochemical activity is presentation of a dual-phosphorylated ITAM to the tandem SH2 domains of Syk, which it binds with high affinity (Kd ~1.4 nM) in a cooperative, orientation-specific manner, whereas monophosphorylated ITAM binds far more weakly [#0]; multivalent cis and trans docking configurations on γ homodimers, tuned by Syk Y130 autophosphorylation and by the spacing between paired ITAMs, further govern Syk recruitment [#14]. ITAM tyrosine phosphorylation is a discrete, druggable initiation step in receptor signaling [#5, #17], and the assembled FcεRIγ/Syk module drives downstream activation through the Syk/AKT/NF-κB axis to mediate effector functions such as antibody-dependent cytotoxicity [#19]. FcεRIγ acts as an obligate assembly and trafficking partner for partner receptors: it is rate-limiting for surface expression of FcεRIα, allowing it to mature past the ER and traffic to the cell surface [#3], and it stabilizes the surface expression of NK-cell activating receptors NKp46 and NKp30 [#12, #11]. Through transmembrane charge-pair interactions it serves as the activating adaptor for diverse receptors including PIR-A, NKp46, Mincle/MCL, DCAR1, and activating KIR, enabling phagocytosis, ROS production, nitric oxide release, and cytotoxicity [#2, #4, #7, #13, #15]. FcεRIγ abundance is controlled at multiple levels: its transcription is repressed by FCER1G promoter DNA methylation and induced upon demethylation [#6, #8], its surface availability is coupled to proliferation/mTOR signaling [#16], and its protein stability is set by a K48-ubiquitylation switch in which Cbl-b targets it for degradation and the deubiquitylase USP5 reverses this to stabilize it [#18]. Beyond its canonical activating role, FcεRIγ on myeloid antigen-presenting cells negatively regulates extrafollicular B-cell responses in a CD40L-dependent manner [#10], and it can substitute for ζ/η chains in the TCR complex during T-cell development [#1].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established the core biochemical logic of FcεRIγ signaling: how the phosphorylated ITAM is read by Syk, defining affinity, cooperativity, and orientation requirements.\",\n      \"evidence\": \"In vitro scintillation proximity and competition binding with 125I-ITAM peptides and SH2-domain knockout mutants\",\n      \"pmids\": [\"8810294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Performed with isolated peptides and domains, not intact receptor complexes\", \"Did not address kinase activation downstream of docking\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed FcεRIγ is functionally interchangeable with ζ/η chains as a TCR signal-transducing subunit, revealing a shared ITAM-adaptor role across receptor families.\",\n      \"evidence\": \"Single and triple ζ-family knockout mice analyzed for αβ-T cell development by flow cytometry\",\n      \"pmids\": [\"9529325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular signaling differences between γ and ζ in the TCR\", \"Low residual T cell numbers leave quantitative contribution unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined the transmembrane charge-pair mechanism by which a partner receptor (PIR-A3) physically engages FcεRIγ to deliver activation signals.\",\n      \"evidence\": \"Chimeric receptor cotransfection, co-IP with endogenous FcεRIγ, Arg632 point mutant, and nitric oxide functional assay\",\n      \"pmids\": [\"10477705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single receptor pairing; generality across receptors not yet shown\", \"Downstream signaling steps not dissected\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed FcεRIγ as an obligate assembly/trafficking chaperone, rate-limiting for surface delivery of FcεRIα.\",\n      \"evidence\": \"Reciprocal co-IP, glycosylation maturation analysis, and confocal colocalization in monocyte-derived dendritic cells\",\n      \"pmids\": [\"12671054\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of ER-to-Golgi escort not resolved at structural level\", \"Did not address whether γ chaperones other partner receptors similarly\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Extended the adaptor role to NK cytotoxicity by showing NKp46 uses FcεRIγ (and CD3ζ) for signal transduction.\",\n      \"evidence\": \"Co-IP from activated NK cells with redirected lysis and F(ab')2 blocking\",\n      \"pmids\": [\"15356098\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Rat system; single lab\", \"Relative contribution of γ vs ζ not quantified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Isolated ITAM tyrosine phosphorylation as a discrete, separable step in signaling, distinct from receptor expression and assembly.\",\n      \"evidence\": \"Pharmacological inhibition (azelastine) with phospho-γ Western blot and mRNA/protein controls in RBL-2H3 cells\",\n      \"pmids\": [\"17499203\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell line and single drug\", \"Did not identify the kinase responsible for the phosphorylation step\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified FCER1G promoter DNA methylation as a causal transcriptional control point governing FcεRIγ and surface FcεRI levels.\",\n      \"evidence\": \"Bisulfite sequencing, patch-methylation luciferase reporter, and 5-azacytidine demethylation in monocytes\",\n      \"pmids\": [\"22150093\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Methyltransferases/demethylases acting at the locus not identified\", \"Physiological signals controlling methylation state unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Confirmed and extended the methylation-dependent repression of the FCER1G promoter and showed γ assembly into a Mincle/MCL trimeric complex enhances phagocytosis.\",\n      \"evidence\": \"Patch-methylation luciferase reporter; co-IP, flow cytometry, and phagocytosis assays in rat cells\",\n      \"pmids\": [\"23456064\", \"23921530\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reporter assays are in vitro reconstitutions\", \"Stoichiometry and surface organization of the trimeric complex not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed that ITAM tyrosines recruit effectors beyond Syk, coupling FcεRIγ to type II PtdIns 4-kinase upon receptor ligation.\",\n      \"evidence\": \"Anti-FcεRIγ IP with PtdIns 4-kinase activity assay and Y65F/Y76F ITAM mutants in RBL-2H3 cells\",\n      \"pmids\": [\"24481753\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect (Syk-bridged) association not distinguished\", \"Functional consequence of lipid kinase coupling not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Uncovered a negative-regulatory role for FcεRIγ on myeloid APCs in restraining B-cell responses, broadening its biology beyond direct activation.\",\n      \"evidence\": \"Adoptive transfer into Fcer1g-/- and Myd88-/- mice with CD40L blockade epistasis\",\n      \"pmids\": [\"28659358\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor delivering the suppressive signal not identified\", \"Molecular mechanism of CD40L-dependent downregulation unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked FcεRIγ induction (via demethylation) to functional acquisition of NKp30 and NK-like cytotoxicity in CD8+ T cells.\",\n      \"evidence\": \"IL-15 stimulation, promoter demethylation analysis, cytotoxicity assays, and xenograft model\",\n      \"pmids\": [\"29895693\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative coupling of γ, Syk, and PLZF; causal ordering not established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the biophysics of Syk recruitment (cis/trans multivalent docking, ITAM spacing, Y130 autophosphorylation bias) and showed FcεRIγ stabilizes NKp46 surface protein independent of transcription, with in vivo immunological consequences.\",\n      \"evidence\": \"MD/polymer modeling with γ-KO reconstitution and engineered constructs; Fcer1g-/- mice in LCMV infection; co-IP/functional assays for DCAR1\",\n      \"pmids\": [\"31216232\", \"31220194\", \"31134097\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model of the multivalent docking states not experimentally resolved\", \"Mechanism by which γ stabilizes partner surface protein not molecularly defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated adaptor specificity, showing activating KIR3DS05 selectively pairs with FcεRIγ rather than DAP12 for ligand-triggered signaling.\",\n      \"evidence\": \"Co-IP in transfected and primary cells with MHC-I ligand signaling assays\",\n      \"pmids\": [\"33968088\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of adaptor selectivity not defined\", \"Rhesus system; single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified proliferation/mTOR signaling as a post-transcriptional determinant of FcεRIγ protein abundance in NK cells.\",\n      \"evidence\": \"Cytokine and mTOR-inhibitor treatments of NK cells with in vivo rapamycin clinical correlation\",\n      \"pmids\": [\"36066491\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between mTOR/proliferation and γ protein levels not defined\", \"Correlative in vivo data\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Validated the FcεRIγ ITAM–Syk-tSH2 interface as a tractable drug target via covalent small-molecule disruptors.\",\n      \"evidence\": \"HTS with TR-FRET and orthogonal PPI assays plus biophysical characterization of covalent SYK-tSH2 modification\",\n      \"pmids\": [\"38359047\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cellular and in vivo efficacy not established\", \"Selectivity against other tSH2 proteins not characterized\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established a ubiquitin-based control of FcεRIγ stability, defining the Cbl-b/USP5 K48-ubiquitylation switch that tunes mast cell activation.\",\n      \"evidence\": \"Co-IP, K48-linkage-specific ubiquitylation assays, USP5 siRNA/inhibitor, and in vivo mouse allergy models\",\n      \"pmids\": [\"40729432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals that regulate Cbl-b/USP5 activity toward γ unknown\", \"Whether this axis operates in non-mast-cell lineages not tested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Mapped the full effector signaling axis (FcεRIγ/Syk/AKT/NF-κB) underlying antibody-dependent cytotoxicity in double-negative T cells.\",\n      \"evidence\": \"Fcer1g-KO DNT cells, Syk inhibitor epistasis, phospho-AKT/NF-κB Western blots, and subcutaneous tumor model\",\n      \"pmids\": [\"41481135\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intermediate steps between Syk and AKT/NF-κB not delineated\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse upstream regulatory inputs (DNA methylation, mTOR/proliferation, and Cbl-b/USP5 ubiquitylation) are integrated to set FcεRIγ levels in a given cell, and the structural basis of its selective pairing with distinct partner receptors, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking transcriptional, translational, and degradative control\", \"No high-resolution structure of γ–partner-receptor transmembrane assemblies\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 4, 7, 13, 15]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": []}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 7, 12]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 10, 12, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 14, 19]}\n    ],\n    \"complexes\": [\n      \"FcεRI (high-affinity IgE receptor)\",\n      \"Mincle/MCL/FcεRIγ trimeric complex\",\n      \"TCR-CD3 complex\"\n    ],\n    \"partners\": [\n      \"SYK\",\n      \"FCER1A\",\n      \"NCR1 (NKp46)\",\n      \"NCR3 (NKp30)\",\n      \"CLEC4D (MCL)\",\n      \"USP5\",\n      \"CBLB\",\n      \"PIRA\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}